Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression
about
The 4.1/ezrin/radixin/moesin domain of the DAL-1/Protein 4.1B tumour suppressor interacts with 14-3-3 proteinsSuppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cellsDAL-1/4.1B tumor suppressor interacts with protein arginine N-methyltransferase 3 (PRMT3) and inhibits its ability to methylate substrates in vitro and in vivoIdentification of 5 novel genes methylated in breast and other epithelial cancers.Loss, mutation and deregulation of L3MBTL4 in breast cancers.Whole genome analysis of genetic alterations in small DNA samples using hyperbranched strand displacement amplification and array-CGH.Protein 4.1B suppresses prostate cancer progression and metastasis.The membrane-cytoskeletal protein 4.1N is involved in the process of cell adhesion, migration and invasion of breast cancer cellsAberrant expression of the candidate tumor suppressor gene DAL-1 due to hypermethylation in gastric cancer.Myelofibrosis involving lymph node: a novel cytogenetic abnormality in a mimicker of mesenchymal neoplasm.Tumor suppressor role of protein 4.1B/DAL-1.Epb41l3 suppresses esophageal squamous cell carcinoma invasion and inhibits MMP2 and MMP9 expression.Aberrant expression of tumor suppressors CADM1 and 4.1B in invasive lesions of primary breast cancer.Loss of protein tyrosine phosphatase, non-receptor type 2 is associated with activation of AKT and tamoxifen resistance in breast cancer.4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.Studying the heterogeneity of brain tumors using medium throughput LOH analysis.
P2860
Q24534317-3226316E-2643-4A61-AC43-CEF9975C81E4Q28214499-B5F0C4F1-17D3-475D-A5F9-3902DB8507C4Q28279298-1D4538E6-3CB7-48C5-B069-180A64274109Q33737079-41B331E5-8FA2-4B86-BACF-6722D309D1BFQ34105097-7098C398-4772-4AD3-919C-B99BE25C73CBQ34373539-9D630661-464E-4D55-8D94-0CE42E5405CBQ35901782-A90B53C4-9675-4E4F-B091-BF21AB5A6075Q36409185-27D8C4E2-EA14-41F6-844A-177692E79D13Q36628545-3CC01F9B-CBAB-456B-9D39-C1880432ACA6Q37397730-F72A16DA-D6FC-4894-9A6E-F46F3429AF0CQ38245653-B2AED6C4-E9C4-4006-ADEA-9C89077CA4B8Q38791022-A10856EC-06A0-4923-9A72-D9BB15D54E53Q39551556-1EB2B1BE-BCB2-4C6E-8F5A-68B0A361C043Q41550474-44F37F94-F27C-457F-907E-DD9677A07DACQ51623514-A979FEF5-44A8-4C07-9CEC-A82FFAB513E5Q55473834-C2B7E1C9-BB4A-41DB-83A5-60377A824FC6
P2860
Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression
description
2001 nî lūn-bûn
@nan
2001 թուականին հրատարակուած գիտական յօդուած
@hyw
2001 թվականին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Allelic loss on chromosome ban ...... y in breast cancer progression
@ast
Allelic loss on chromosome ban ...... y in breast cancer progression
@en
Allelic loss on chromosome ban ...... y in breast cancer progression
@nl
type
label
Allelic loss on chromosome ban ...... y in breast cancer progression
@ast
Allelic loss on chromosome ban ...... y in breast cancer progression
@en
Allelic loss on chromosome ban ...... y in breast cancer progression
@nl
prefLabel
Allelic loss on chromosome ban ...... y in breast cancer progression
@ast
Allelic loss on chromosome ban ...... y in breast cancer progression
@en
Allelic loss on chromosome ban ...... y in breast cancer progression
@nl
P2093
P2860
P356
P1476
Allelic loss on chromosome ban ...... y in breast cancer progression
@en
P2093
F Dalbegue
I F Newsham
K Kittiniyom
P2860
P2888
P356
10.1186/BCR294
P407
P577
2001-01-01T00:00:00Z
P5875
P6179
1014199990